Segment Information (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Schedule of Significant Segment Expenses

Significant segment expenses are set forth in the following table (in thousands):

	Year Ended December 31,
	2023			2022
	(Restated)
Revenue	$	53,467		$	64,211
Less:
Cost of revenue		11,970			13,485
Sales and marketing		46,857			50,405
Clinical trials and medical affairs		15,700			5,183
Product development		4,477			4,586
Digital		4,451			3,945
Quality and regulatory		3,066			3,252
General and administrative		46,024			15,365
Other segment items (1)		3,739			5,734
Net loss		(82,817	)		(37,744	)

(1) Other segment items included in Net loss primarily include changes in fair value of warrant liabilities, changes in fair value of debt, changes in fair value of the Revenue Interest Financing, loss on extinguishment of debt, interest expense, and other income.

Schedule of Long-lived Assets by Geography

Long-lived assets, consisting of property and equipment, net and ROU assets by geography were as follows (in thousands):

	December 31,
	2023		2022
United States	$	5,381	$	3,999
France		1,010		1,282
All other countries		—		—
Long-lived assets	$	6,391	$	5,281